Sagimet Biosciences Inc. Series A Common Stock
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 61.47 | -100% | -5.69 | -100% |
| P/S |
|
69.43 | 33.58 | 106.77% |
|
|
| P/BV |
|
1.52 | 4.79 | -68.18% |
|
|
| P/FCF |
|
0 | 60.06 | -100% |
|
|
| Ev/Ebitda |
|
-2.08 | -17.26 | -87.98% |
|
|
| Ev/S |
|
31.9 | 22.49 | 41.85% |
|
|
| Ev/FCF |
|
-2.68 | 67.63 | -103.97% |
|
|
| E/P |
|
0 | 0.0168 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-1537.2 | 4.5 | -34287.11% | -1537 | +0.013% |
| ROE |
|
-30.61 | 9.39 | -425.95% |
|
|
| ROA |
|
-28.82 | 0.1519 | -19071.03% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-1393.8 | -25.64 | 5335.9% |
|
|
| ROCE |
|
-67.52 | 15.19 | -544.6% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0021 | -3.68 | -99.94% | -0.0056 | -61.99% |
| Nеt Debt/Ebitda |
|
2.44 | -4.07 | -160.05% |
|
|
| Debt/Ratio |
|
0.000672 | 0.199 | -99.66% |
|
|
| Debt/Equity |
|
0 | 1.67 | -100% |
|
|
| Debt/Net Income |
|
-0.0023 | 10.34 | -100.02% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5399 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2331 | -100% |
|
|
| Average dividend growth |
|
0 | 1.07 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4916 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.32 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5399 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
0 | 76.2 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
116.48 | 44.75 | 160.29% | ||
| Growth impulse Net Income in 5 years |
|
94.94 | -15.36 | -718.1% | ||
| Growth impulse FCF in 5 years |
|
124.21 | -9.39 | -1422.79% | ||
| Growth impulse EPS in 5 years |
|
314.39 | -84.03 | -474.14% |
IP Score
4.25/10
